

South San Francisco-based Therini Bio, a vascular biology company, has secured $17 million in funding. The investors included SV, MRL Ventures and Sanofi Ventures.
Source: Press Release
South San Francisco-based Therini Bio, a vascular biology company, has secured $17 million in funding.
South San Francisco-based Therini Bio, a vascular biology company, has secured $17 million in funding. The investors included SV, MRL Ventures and Sanofi Ventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination